🔥🐔 BizChicken 🐔🔥
Companies Similar to Cardiff Oncology, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
Ikena Oncology, Inc.
IK-930
Ikena Oncology is a targeted oncology company developing medicines tailored to biomarker-defined patient groups, with a focus on unmet needs in cancer treatment.
Symbol: IKNA
Recent Price: $1.60
Industry: Biotechnology
CEO: Dr. Mark Manfredi Ph.D.
Sector: Healthcare
Employees: 18
Address: 645 Summer Street, Boston, MA 02210
Phone: 857 273 8343
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Agenus Inc.
Retrocyte Display
Agenus Inc. is a clinical-stage immuno-oncology company that discovers and develops immuno-oncology products, offering antibody expression platforms, vaccine programs, and various monoclonal antibodies for cancer treatment.
Symbol: AGEN
Recent Price: $2.69
Industry: Biotechnology
CEO: Dr. Garo H. Armen Ph.D.
Sector: Healthcare
Employees: 389
Address: 3 Forbes Road, Lexington, MA 02421-7305
Phone: 781 674 4400
Last updated: 2024-12-31
ALX Oncology Holdings Inc.
ALX148
ALX Oncology Holdings Inc. is a clinical-stage immuno-oncology company developing therapies for cancer patients. Its lead product, ALX148, targets CD47 and is in trials for various cancers. The company also explores pre-clinical treatments like ALTA-002 to enhance immune response to cancer.
About | Contact | About | About | Careers | Careers | Jobs | Jobs | Jobs | Jobs | Careers | About | About | Careers | Jobs
Symbol: ALXO
Recent Price: $1.66
Industry: Biotechnology
CEO: Mr. Jason W. Lettmann
Sector: Healthcare
Employees: 81
Address: 323 Allerton Avenue, South San Francisco, CA 94080
Phone: 650 466 7125
Last updated: 2024-12-31
American Oncology Network, Inc.
Oncology Services
American Oncology Network, Inc. provides comprehensive oncology services, including laboratory, pathology, specialty pharmacy, and care management support services in the United States.
Symbol: AONC
Recent Price: $4.94
Industry: Medical - Care Facilities
CEO: Mr. Todd Schonherz
Sector: Healthcare
Employees: 1525
Address: 14543 Global Parkway, Fort Myers, FL 33913
Phone: 833-886-1725
Last updated: 2024-12-31
Arvinas, Inc.
Bavdegalutamide, ARV-471, ARV-766
Arvinas, Inc. is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of therapies to degrade disease-causing proteins. The company is based in New Haven, Connecticut and collaborates with organizations like Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG.
About | Leadership | Contact | Culture | Culture | Culture | About | News | Events | ESG | About | About | About | About | About | About | About | About | About | About | About | About | Events | ESG | About | About | About | About | About | About | About | Culture | Culture | Vision/Values | Culture | Careers | About | About | About | About | News | About | About | Contact | About | About
Symbol: ARVN
Recent Price: $19.00
Industry: Biotechnology
CEO: Dr. John G. Houston Ph.D.
Sector: Healthcare
Employees: 445
Address: 5 Science Park, New Haven, CT 06511
Phone: 203 535 1456
Leadership
- John G. Houston, Ph.D., Chairperson, Chief Executive Officer, and President
- Noah Berkowitz, M.D., Ph.D., Chief Medical Officer
- Angela M. Cacace, Ph.D., Chief Scientific Officer
- Jared Freedberg, J.D., General Counsel and Corporate Secretary
- Paul McInulty, Senior Vice President, Regulatory Affairs
- John Northcott, Chief Commercial Officer
- Kelly Page, Senior Vice President, Global Head of Oncology Strategy and Program Leadership
- Andrew Saik, Chief Financial Officer
- Lisa Sinclair, Senior Vice President, Corporate Operations
- Ian Taylor, Ph.D., President, R&D
- Randy Teel, Ph.D., Chief Business Officer
- Steve Weiss, Senior Vice President, Chief Human Resources Officer
Last updated: 2024-12-31
Context Therapeutics Inc.
onapristone extended release (ONA-XR)
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments for women in the United States. Its main product, ONA-XR, is aimed at resistant female hormone-dependent cancers.
Symbol: CNTX
Recent Price: $1.06
Industry: Biotechnology
CEO: Mr. Martin A. Lehr
Sector: Healthcare
Employees: 5
Address: 2001 Market Street, Philadelphia, PA 19103
Phone: 267 225 7416
Last updated: 2024-12-31
Cardiff Oncology, Inc.
Onvansertib
Cardiff Oncology, Inc. is a clinical-stage oncology company developing treatment medicine for cancer patients, featuring lead drug candidate onvansertib, targeting various cancers including colorectal cancer. The company is headquartered in San Diego, California.
Symbol: CRDF
Recent Price: $4.26
Industry: Biotechnology
CEO: Dr. Mark Erlander Ph.D.
Sector: Healthcare
Employees: 31
Address: 11055 Flintkote Avenue, San Diego, CA 92121
Phone: 858 952 7570
Last updated: 2024-12-31
Champions Oncology, Inc.
Tumorgraft Technology Platform
Champions Oncology, Inc. specializes in personalized cancer care technology solutions, including the Tumorgraft Technology Platform and Lumin Bioinformatics, aimed at enhancing oncology drug development and usage.
Symbol: CSBR
Recent Price: $8.62
Industry: Biotechnology
CEO: Dr. Ronnie Morris M.D.
Sector: Healthcare
Employees: 210
Address: One University Plaza, Hackensack, NJ 07601
Phone: 201 808 8400
Last updated: 2024-12-31
Elevation Oncology, Inc.
seribantumab
Elevation Oncology, Inc. is a clinical-stage biopharmaceutical company focused on developing therapeutics for the treatment of cancer in genomically defined patient populations. Their lead program is seribantumab, an anti-HER3 monoclonal antibody for advanced solid tumors.
Symbol: ELEV
Recent Price: $0.57
Industry: Biotechnology
CEO: Mr. Joseph J. Ferra Jr.
Sector: Healthcare
Employees: 29
Address: 888 Seventh Avenue, New York, NY 10106
Phone: 716 371 1125
Last updated: 2024-12-31
Kintara Therapeutics, Inc.
VAL-083, REM-001
Kintara Therapeutics is a clinical stage drug development company focused on developing and commercializing anti-cancer therapies for drug-resistant solid tumors.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About
Symbol: KTRA
Recent Price: $0.22
Industry: Biotechnology
CEO: Mr. Jeffrey A. Bacha B.Sc., M.B.A.
Sector: Healthcare
Employees: 1
Address: 12707 High Bluff Drive, San Diego, CA 92130
Phone: 858 350 4364
Leadership
- Robert E. Hoffman, President, CEO, CFO and Chairman of the Board
- Greg A. Johnson, (Acting) Head of Operations
- Laura Johnson, Director
- Tamara A. Favorito, Director
- Robert J. Toth, Jr., M.B.A., Director
Last updated: 2024-12-31
Kura Oncology, Inc.
ziftomenib and tipifarnib
Kura Oncology, Inc. is a clinical-stage biopharmaceutical company developing small molecule medicines for the treatment of cancer. It focuses on genetically defined subsets of acute leukemias and has a collaboration with Novartis for certain carcinoma treatments.
Symbol: KURA
Recent Price: $8.51
Industry: Biotechnology
CEO: Dr. Troy Edward Wilson J.D., Ph.D.
Sector: Healthcare
Employees: 142
Address: 12730 High Bluff Drive, San Diego, CA 92130
Phone: 858 500 8800
Last updated: 2024-12-31
Nkarta, Inc.
NKX101 and NKX019
Nkarta, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing cell therapies for the treatment of cancer. The company specializes in cellular immunotherapy using chimeric antigen receptors on natural killer cells to target tumor antigens.
About | Contact | Careers | Careers | Careers | Jobs | Careers | Careers | Careers | Careers | Careers | Careers | Contact | Careers | About | Careers
Symbol: NKTX
Recent Price: $2.32
Industry: Biotechnology
CEO: Mr. Paul J. Hastings
Sector: Healthcare
Employees: 150
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 415 582 4923
Last updated: 2024-12-31
Onconetix, Inc.
Entadfi
Onconetix, Inc. is a biotechnology and pharmaceutical company focused on developing and commercializing transformative therapies to address global health challenges. The company’s products include Entadfi for benign prostatic hyperplasia and various innovative vaccine candidates.
Symbol: ONCO
Recent Price: $0.44
Industry: Biotechnology
CEO: Dr. Ralph Schiess Ph.D.
Sector: Healthcare
Employees: 12
Address: 201 East Fifth Street, Cincinnati, OH 45202
Phone: 513 620 4101
Last updated: 2024-12-31
Outlook Therapeutics, Inc.
ONS-5010
Outlook Therapeutics, Inc. is a late clinical-stage biopharmaceutical company focused on developing and commercializing monoclonal antibodies for ophthalmic indications, with its lead product candidate ONS-5010 in Phase-III clinical trial for treating wet age-related macular degeneration and other retina diseases.
About | About | Leadership | Directors | About | Contact | Careers | Careers | Careers | Jobs | About | About
Symbol: OTLK
Recent Price: $1.86
Industry: Biotechnology
CEO: Mr. C. Russell Trenary III
Sector: Healthcare
Employees: 24
Address: Building F, Iselin, NJ 08852
Phone: 609 619 3990
Leadership
- Randy Thurman, Executive Chairman
- Yezan Haddadin, Member of the Board of Directors
- Kurt J. Hilzinger, Member of the Board of Directors
- Julia A. Haller, MD, Member of the Board of Directors
- C. Russell Trenary III, President, Chief Executive Officer, and Member of the Board
- Lawrence A. Kenyon, Chief Financial Officer and Member of the Board
- Faisal G. Sukhtian, Executive Director
- Julian Gangolli, Member of the Board of Directors
- Gerd Auffarth, MD, Member of the Board of Directors
- Andong Huang, Vice President, Business Development
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
Cullinan Oncology, Inc.
CLN-081
Cullinan Oncology Inc., a biopharmaceutical company, focuses on developing a pipeline of targeted oncology and immuno-oncology therapies for cancer patients in the United States. Their lead candidate, CLN-081, is in a trial for treating non-small cell lung cancer. The company also has several preclinical products targeting various forms of cancer.
Symbol: CGEM
Recent Price: $12.20
Industry: Biotechnology
CEO: Mr. Nadim Ahmed
Sector: Healthcare
Employees: 85
Address: One Main Street, Cambridge, MA 02142
Phone: 617 410 4650
Last updated: 2024-12-31
The Oncology Institute, Inc.
Medical Oncology Services
An oncology company providing medical oncology services in the United States, including clinical trials, radiation, outpatient stem cell transplants, and patient support, serving adult and senior cancer patients with 67 clinic locations.
About | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: TOI
Recent Price: $0.32
Industry: Medical - Care Facilities
CEO: Dr. Daniel Virnich FACHE, M.B.A., M.D.
Sector: Healthcare
Employees: 800
Address: 18000 Studebaker Road, Cerritos, CA 90703
Phone: 213 760 1328
Last updated: 2024-12-31
Viracta Therapeutics, Inc.
Nana-val
Viracta Therapeutics, Inc. is a precision oncology company focused on developing drugs for the treatment of virus-associated malignancies, with a lead product candidate Nana-val in clinical trials for Epstein-Barr virus-positive lymphoma and other related conditions.
Leadership | Contact | Careers | About | Careers | About | About | About | About | About | About
Symbol: VIRX
Recent Price: $0.16
Industry: Biotechnology
CEO: Mr. Mark Andrew Rothera
Sector: Healthcare
Employees: 40
Address: 2533 South Coast Highway 101, Cardiff-by-the-Sea, CA 92007
Phone: 858 400 8470
Leadership
- Mark Rothera, President and Chief Executive Officer
- Darrel P. Cohen, M.D., Ph.D., Chief Medical Officer
- Ayman Elguindy, Ph.D., Chief Scientific Officer
- Michael Faerm, MBA, Chief Financial Officer
- Cheryl Madsen, Senior Vice President, Regulatory
- Patric Nelson, MBA, Senior Vice President, Business Development & Corporate Strategy
- Biljana Nadjsombati, Pharm.D., Senior Vice President, Pharmaceutical Development
- Violetta Akopian, Ph.D., Vice President, Quality Assurance
- Ruby Cheema, Vice President, Portfolio and Program Management
- Mark A. McCamish, M.D., Ph.D., Strategic Advisor
- Roger J. Pomerantz, M.D., Chairman of the Board
- Jane F. Barlow, M.D., MPH, MBA, Director
- Flavia Borellini, Ph.D., Director
- Jane Chung, R.Ph., Director
- Thomas E. Darcy, CPA, Director
- Sam Murphy, Ph.D., Director
- Ivor Royston, M.D., Director
- Stephen Rubino, Ph.D., MBA, Director
- Barry J. Simon, M.D., Director
- Douglas V. Faller, M.D., Ph.D., Scientific Founder and Chairman, Scientific Advisory Board
- Robert Baiocchi, M.D., Ph.D., Scientific Advisor
- Gavin Giovannoni, MBBCh, Ph.D., FCP (Neurol., SA), FRCP, FRCPath, Scientific Advisor
- Carl June, M.D., Scientific Advisor
- Shannon Kenney, M.D., Scientific Advisor
- Ronald Levy, M.D., Scientific Advisor
- Pierluigi Porcu, M.D., Scientific Advisor
- Daniel D. Von Hoff, M.D., F.A.C.P. FASCO, FAACR, Scientific Advisor
- Lawrence Young, Ph.D., Scientific Advisor
Last updated: 2024-12-31